| Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors H Janouskova, G El Tekle, E Bellini, ND Udeshi, A Rinaldi, A Ulbricht, ... Nature medicine 23 (9), 1046-1054, 2017 | 176 | 2017 |
| Bacteria in cancer initiation, promotion and progression G El Tekle, WS Garrett Nature Reviews Cancer 23 (9), 600-618, 2023 | 150 | 2023 |
| Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us G El Tekle, T Bernasocchi, AM Unni, F Bertoni, D Rossi, MA Rubin, ... Trends in cancer 7 (9), 823-836, 2021 | 56 | 2021 |
| Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer T Bernasocchi, G El Tekle, M Bolis, A Mutti, A Vallerga, LP Brandt, ... Nature communications 12 (1), 734, 2021 | 40 | 2021 |
| Crystal structures of OrfX2 and P47 from a Botulinum neurotoxin OrfX‐type gene cluster R Gustafsson, RPA Berntsson, M Martínez‐Carranza, G El Tekle, ... FEBS letters 591 (22), 3781-3792, 2017 | 23 | 2017 |
| De novo variants in SPOP cause two clinically distinct neurodevelopmental disorders MJN Sá, G El Tekle, APM de Brouwer, SL Sawyer, D Del Gaudio, ... The American Journal of Human Genetics 106 (3), 405-411, 2020 | 15 | 2020 |
| The role of the microbiome in the etiopathogenesis of colon cancer G El Tekle, N Andreeva, WS Garrett Annual Review of Physiology 86 (1), 453-478, 2024 | 10 | 2024 |
| SPOP: One Gene, Two Distinct Neurodevelopmental Phenotypes MJ Sa, G El Tekle, APM de Brouwer, SL Sawyer, D del Gaudio, MJ Parker, ... EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 363-364, 2020 | | 2020 |
| Functional Characterization and Therapeutic Implications of SPOP Mutations in Endometrial and Prostate Cancer G El Tekle éditeur non identifié, 2020 | | 2020 |
| Opposing therapeutic efficacy of BET inhibitors is determined by cancer type-specific SPOP mutants H Janouskova, G El Tekle, N Udeshi, A Ulbricht, A Rinaldi, G Civenni, ... European Journal of Cancer 69, S2, 2016 | | 2016 |
